» Articles » PMID: 38523861

Prospective Analysis of Lipid Variations in Hyperthyroid Subjects from Lahore, Pakistan

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2024 Mar 25
PMID 38523861
Authors
Affiliations
Soon will be listed here.
Abstract

Perturbations in the actions of T and T influence the normal metabolic pathways. Responsiveness of lipid biomarkers like LDL-C, HDL-C, TC, TG, Apo-A, and Apo-B after rehabilitation of thyroid profile attaining euthyroid state was determined. A total of 179 age-matched subjects of both genders were recruited for this research. Sixty healthy controls, thirty-four subclinical, fifty overt hyperthyroid, and thirty-five follow-up subjects having 3 months of Carbimazole therapy were enrolled. Biochemical analysis was performed by chemistry analyzer, RIA, and ELISA. One-way ANOVA was applied for the statistical analysis, while significance ( < 0.05) of means was compared by the Student-Newman-Keuls (SNK) test. Pronounced reduction ( < 0.001) of cholesterol in overt as compared to control and subclinical was noticed, whereas marked improvement ( < 0.001) was evidenced in follow-up. Prominent elevation ( < 0.05) of TG in follow-up was evidenced as compared to control. Overt presented marked reduction of HDL-C as compared to subclinical and control ( < 0.01 and < 0.001), respectively. Pronounced elevation ( < 0.001) of HDL-C was evidenced after treatment. Overt presented reduction of LDL-C as compared to subclinical and control ( < 0.01 and < 0.05, respectively). The follow-up group demonstrated considerable ( < 0.001) improvement of LDL-C after treatment and elevation ( < 0.05) as compared to control. Overt presented reduction of Apo-B as compared to subclinical and control ( < 0.05 and < 0.001, respectively). Improvement ( < 0.05) of Apo-B was evidenced in follow-up. Reduction ( < 0.05) of Apo-A in overt as compared to control and elevation ( < 0.05) in follow-up as compared to overt was evidenced. Conclusively, improvement after treatment was evidenced in lipid profile.

Citing Articles

Elevated Free Thyroxine Levels Might Alter the Effect of the Lipid Profile on Insulin Resistance in Type 2 Diabetes Mellitus.

Lee Y, Yang T, Lin Y, Hsieh Y Diagnostics (Basel). 2023; 13(16).

PMID: 37627914 PMC: 10453194. DOI: 10.3390/diagnostics13162656.


Corrigendum to "Prospective Analysis of Lipid Variations in Hyperthyroid Subjects from Lahore, Pakistan".

Iqbal M, Ahmad S, Mumtaz T, Naseem Z, Malik J, Ahmad H Biomed Res Int. 2022; 2022:9815891.

PMID: 35041727 PMC: 8758262. DOI: 10.1155/2022/9815891.

References
1.
Delitala A, Steri M, Pilia M, Dei M, Lai S, Delitala G . Menopause modulates the association between thyrotropin levels and lipid parameters: The SardiNIA study. Maturitas. 2016; 92:30-34. PMC: 5501284. DOI: 10.1016/j.maturitas.2016.07.003. View

2.
Mogulkoc R, Dasdelen D, Baltaci S, Baltaci A, Sivrikaya A . The effect of thyroid dysfunction and treatment on adropin, asprosin and preptin levels in rats. Horm Mol Biol Clin Investig. 2021; 42(1):37-42. DOI: 10.1515/hmbci-2020-0058. View

3.
Natarajan P, Ray K, Cannon C . High-density lipoprotein and coronary heart disease: current and future therapies. J Am Coll Cardiol. 2010; 55(13):1283-99. DOI: 10.1016/j.jacc.2010.01.008. View

4.
Minarikova Z, Gaspar L, Kruzliak P, Celecova Z, Oravec S . The effects of treatment on lipoprotein subfractions evaluated by polyacrylamide gel electrophoresis in patients with autoimmune hypothyroidism and hyperthyroidism. Lipids Health Dis. 2014; 13:158. PMC: 4210611. DOI: 10.1186/1476-511X-13-158. View

5.
Ness G, Lopez D, Chambers C, Newsome W, Cornelius P, Long C . Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression. Biochem Pharmacol. 1998; 56(1):121-9. DOI: 10.1016/s0006-2952(98)00119-1. View